Oric Pharmaceuticals (ORIC) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

Oric Pharmaceuticals

· ORIC

Dashboard

Financials

Ratios

Valuation

Statistics

1.265 B

+2.34%

Oric Pharmaceuticals (ORIC) Company Statistics | The Fly

General

Market Cap: $1.27B
Enterprise Value: $1.26B
Shares Outstanding: 103,520,000
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: —
Operating Margin: —
Net Profit Margin: —
FCF Margin: —
ROA: -34.68%
ROE: -35.35%
ROIC: -40.32%
Current Ratio: 13.19
Debt-to-Equity: 0.01
Revenue Per Employee: —

Valuation (TTM)

P/E: —
PEG: —
P/S: —
P/FCF: —
P/B: 3.39
EV/EBITDA: -8.80

Growth

Rev 1Y: —
Rev 1Y Fwd Est: —
Rev 3Y (CAGR): —
Rev 5Y (CAGR): —
Rev 10Y (CAGR): —
EPS 1Y: —
EPS 1Y Fwd Est: —
EPS 3Y (CAGR): —
EPS 5Y (CAGR): —
EPS 10Y (CAGR): —

Income Statement (TTM)

Revenue: —
Gross Margin: —
Operating Expenses: $155.55M
Operating Income: -$156.14M
Net Profit: -$140.35M

Balance Sheet

Cash and Equivalents: $37.48M
Working Capital: $252.94M
Total Assets: $404.69M
Net Debt: -$34.16M
Total Liabilities: $23.43M
Total Equity: $381.26M

Cash Flow Statement (TTM)

Cash Flow from Operations: -$111.64M
Cash Flow from Investing: -$99.66M
Cash Flow from Financing: $172.92M
Free Cash Flow: -$112.42M
Capital Expenditures: $780K